Cargando…
Adjuvant or radical fractionated stereotactic radiotherapy for patients with pituitary functional and nonfunctional macroadenoma
PURPOSE: To evaluate the efficacy and toxicity of stereotactic fractionated radiotherapy (SFRT) for patients with pituitary macroadenoma (PMA). METHODS AND MATERIALS: Between March 2000 and March 2009, 27 patients (male to female ratio, 1.25) with PMA underwent SFRT (median dose, 50.4 Gy). Mean age...
Autores principales: | Weber, Damien C, Momjian, Shahan, Pralong, François P, Meyer, Patrick, Villemure, Jean Guy, Pica, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248375/ https://www.ncbi.nlm.nih.gov/pubmed/22152397 http://dx.doi.org/10.1186/1748-717X-6-169 |
Ejemplares similares
-
Toxicity Profiles of Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenomas
por: Chang, Chia-Lun, et al.
Publicado: (2019) -
Results of Treatment with Modern Fractionated Radiotherapy, Contemporary Stereotactic Radiosurgery, and Transsphenoidal Surgery in Nonfunctioning Pituitary Macroadenoma
por: Hsiao, Ping-Kun, et al.
Publicado: (2019) -
Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas
por: Elhateer, H., et al.
Publicado: (2008) -
Melanoma metastasis to a nonfunctioning pituitary macroadenoma:
illustrative case
por: Lamorie-Foote, Krista, et al.
Publicado: (2021) -
Clinical Characteristics and Treatment Outcome of 485 Patients with Nonfunctioning Pituitary Macroadenomas
por: Vargas, Guadalupe, et al.
Publicado: (2015)